MATAIRESINOL-4-O-BETA-D-GLUCOPYRANOSIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 8VrUXmhcHmp |
|---|---|
| InChI | InChI=1S/C26H32O11/c1-33-19-9-14(3-5-17(19)28)8-16-15(12-35-25(16)32)7-13-4-6-18(20(10-13)34-2)36-26-24(31)23(30)22(29)21(11-27)37-26/h3-6,9-10,15-16,21-24,26-31H,7-8,11-12H2,1-2H3/t15-,16+,21+,22+,23-,24+,26+/m0/s1 |
| InChIKey | FWRZDNFXFFWBGP-LHHMAMHXSA-N |
| Mol Weight | 520.5 g/mol |
| Molecular Formula | C26H32O11 |
| Exact Mass | 520.194462 g/mol |
| Enantiomer InChIKey | FWRZDNFXFFWBGP-FEWADDIJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
MATAIRESINOL-4'-O-GLUCOPYRANOSIDE
STYRAXLIGNOLIDE-E;(2S,3S)-2-ALPHA-(4''-HYDROXY-3''-METHOXYBENZYL)-3-BETA-(4'-HYDROXY-3'-METHOXYBENZYL)-GAMMA-BUTYROLACTONE-4''-O-(BETA-D-GLUCOPYRAN
STYRAXLIGNOLIDE-F;2-(3'',4''-DIMETHOXYBENZYL)-3-(4'-HYDROXY-3'-METHOXYBENZYL)-GAMMA-BUTYROLACTONE-4'-O-(BETA-D-GLUCOPYRANOSIDE)
ARCTIIN;4'-O-GLUCOPYRANOSIDE-ARCTIGENIN
STYRAXLIGNOLIDE-C;(2S,3S)-2-ALPHA-(3''-HYDROXY-4''-METHOXYBENZYL)-3-BETA-(4'-HYDROXY-3'-METHOXYBENZYL)-GAMMA-BUTYROLACTONE-4'-O-(BETA-D-GLUCOPYRANO
4-DEMETHYL-TRAXILLASIDE;(8R,8'R)-4-HYDROXY-3,3',4-TRIMETHOXY-LIGNAN-9,9'-OLIDE-4'-O-BETA-D-GLUCOPYRANOSIDE
VISCOLIN-4''-O-BETA-D-GLUCOPYRANOSIDE;(4'-HYDROXY-2',3',6',3''-TETRAMETHOXY-1,3-DIPHENYLPROPANE)-4''-O-BETA-D-GLUCOPYRANOSIDE
RHEMANEOLIGNAN-C;4-O-BETA-D-GLUCOPYRANOSIDE-2-BENZHYDRYL-3-HYDROXYMETHYL-BUTANE-1,4-DIOL
(7-R,8-R)-THREO-7,9,9'-TRIHYDROXY-3,3'-DIMETHOXY-8-O-4'-NEOLIGNAN-4-O-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Active Components with Inhibitory Activities on IFN-γ/STAT1 and IL-6/STAT3 Signaling Pathways from Caulis Trachelospermi | Molecules | 2014 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.